Travere Therapeutics Inc (NASDAQ: TVTX) is 36.34% higher on its value in year-to-date trading and has touched a low of $5.12 and a high of $22.25 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TVTX stock was last observed hovering at around $21.10 in the last trading session, with the day’s gains setting it 2.65%.
Currently trading at $23.75, the stock is 16.94% and 24.53% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.41 million and changing 12.56% at the moment leaves the stock 79.61% off its SMA200. TVTX registered 186.14% gain for a year compared to 6-month gain of 178.43%. The firm has a 50-day simple moving average (SMA 50) of $18.9772 and a 200-day simple moving average (SMA200) of $13.131925.
The stock witnessed a 31.29% loss in the last 1 month and extending the period to 3 months gives it a 34.48%, and is 12.56% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.02% over the week and 6.17% over the month.
Travere Therapeutics Inc (TVTX) has around 380 employees, a market worth around $2.07B and $203.45M in sales. Profit margin for the company is -172.78%. Distance from 52-week low is 363.87% and 6.77% from its 52-week high. The company has generated returns on investments over the last 12 months (-117.93%).
with sales reaching $72.63M over the same period.The EPS is expected to shrink by -139.47% this year, but quarterly earnings will post 59.14% year-over-year. Quarterly sales are estimated to grow 61.18% in year-over-year returns.
Travere Therapeutics Inc (TVTX) Top Institutional Holders
The shares outstanding are 87.03M, and float is at 85.72M with Short Float at 11.17%.
The top institutional shareholder in the company is BLACKROCK INC. with over 7.64 million shares valued at $62.84 million. The investor’s holdings represent 9.8642% of the TVTX Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 7.5 million shares valued at $$61.65 million to account for 9.6774 of the shares outstanding. The other top investors are DEEP TRACK CAPITAL, LP which holds 7.37 million shares representing 9.5096% and valued at over $60.58 million, while VANGUARD GROUP INC holds 8.5416 of the shares totaling 6.62 million with a market value of $54.41 million.
Travere Therapeutics Inc (TVTX) Insider Activity
#####
Still, SEC filings show that on Feb 11 ’25, Dube Eric M (Officer) Proposed Sale 11,375 shares at an average price of $24.04 for $0.27 million. The insider now directly holds shares of Travere Therapeutics Inc (TVTX).
